Back to Rankings

ZBIO

Zenas BioPharmaB
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-18
View Chart
+
Peers tracked
11
U.S. public peers
Grade Position
Above peers
vs peer average
ZBIO vs peer average
70/100
ZBIO vs. peer average (B vs. C)
Grade spread
A 2 · C 3 · D 5 · F 1
Graded peers loaded
Coverage
11 graded
100% of tracked

Peer overview

GHRS is the first available peer comparator.

Closest usable packet peer by size, but still a loose same-sector market-cap comp rather than a direct autoimmune/regulatory analog.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerGHRSGH Research
ZBIO
Zenas BioPharma
GHRS
GH Research
Grade
B
C
Momentum
95
92
Value
46
41
Sentiment
44
27
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Mixed

Grade position vs GHRS

ZBIO / GHRS
Grade Position
Above peers
ZBIO vs. peer average (B vs. C)
70/100
Momentum
95
ZBIO
Value
46
ZBIO
Sentiment
44
ZBIO

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs ZBIO
1
GHRS
GHRS
C
60/100
+1
2
CMPS
CMPS
D
40/100
+2
3
AMGN
AMGN
D
40/100
+2
4
MRVI
Maravai Lifesciences Holdings Inc Class A Common
D
40/100
+2
5
HCM
HUTCHMED (China) Ltd ADR
D
40/100
+2
GHRS is the first peer returned for this comparison set.